Scientists around the world continue their efforts to come up with a cure for COVID-19. One drug, remdesivir from U.S. biotech company Gilead, is in clinical trials in China and the United States.
A vaccine could be the magic bullet that would take down the COVID-19 pandemic.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
The rising costs of pharmaceutical drugs has caught the attention of patients who are paying more for their prescriptions.